Royal London Asset Management
IPXL

Royal London Asset Management’s Impax Laboratories, Inc. IPXL Stock Holding History

Royal London Asset Management’s Portfolio IPXL Stock Details IPXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		$1.77M Buy
+61,506
New +$2M 0.03% 479
2016
Q1 		– Sell
-75,383
Closed -$3.29M – 554
2015
Q4 		$3.29M Buy
75,383
+7,356
+11% +$294K 0.05% 373
2015
Q3 		$2.4M Buy
+68,027
New +$3.06M 0.04% 445
2014
Q4 		$23.9K Buy
74,700
+9,400
+14% +$275K 0.05% 403
2014
Q3 		$1.59M Hold
65,300
– – 0.04% 431
2014
Q2 		$1.57M Buy
65,300
+7,700
+13% +$208K 0.04% 468
2014
Q1 		$1.54M Buy
+57,600
New +$1.44M 0.04% 477

Other funds holding IPXL

HP
Hound Partners New York $799M AUM 9.54% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
AG
Aravt Global New York $11.3M AUM 3.78% 1-Year Est. Return
PCM
Pennant Capital Management Summit, New Jersey $212M AUM 19.37% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return

Royal London Asset Management's IPXL Position: Q2 2016 in Review

Royal London Asset Management opened a new position in Impax Laboratories, Inc. (IPXL) in Q2 2016: 61,506 shares worth $1.77M. The stake represents 0.03% of the portfolio and ranks #479 among its holdings. This is a return to the name: Royal London Asset Management previously reported a position in IPXL as recently as Q4 2015.

Royal London Asset Management first reported a position in IPXL in Q1 2014 and has held it in 7 quarters since. The position peaked at $3.29M in Q4 2015. 198 funds tracked by Wall St. Rank hold IPXL as of Q2 2016.

  • Royal London Asset Management held 61,506 shares of Impax Laboratories, Inc. worth $1.77M as of Q2 2016.
  • Impax Laboratories, Inc. was a new Royal London Asset Management position in Q2 2016.
  • Impax Laboratories, Inc. made up 0.03% of Royal London Asset Management's portfolio in Q2 2016, its #479 holding.
  • Royal London Asset Management first reported a position in Impax Laboratories, Inc. in Q1 2014 and has held it in 7 quarters since.
  • Royal London Asset Management's Impax Laboratories, Inc. position peaked at $3.29M in Q4 2015.
  • 198 funds tracked by Wall St. Rank held Impax Laboratories, Inc. as of Q2 2016.

Based on Royal London Asset Management's 13F filing for Q2 2016, filed 2 Aug 2016.